S3 Ep35: Femtech and Inclusive Fertility Care with Tess Cosad, Co-Founder & CEO of Béa Fertility
Femtech is breaking new ground by extending its focus to include menopause and endometriosis, marking a shift from its traditional emphasis on fertility. Despite reaching over $1 billion in global VC investment in 2021, the sector faces criticism for not fully addressing broader health concerns affecting women and LGBTQ+ communities. How can femtech evolve to bridge these critical gaps in healthcare? Consider Béa Fertility, under Tess Cosad's leadership, which is pioneering inclusive, affordable fertility care with its innovative at-home Intracervical Insemination kit, challenging the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.